Skip to main content
SpringerLink
Log in

Momordica charantia L. (Cucurbitaceae)

  • Chapter
  • First Online:
Popular Medicinal Plants in Portland and Kingston, Jamaica

Part of the book series: Advances in Economic Botany ((AEB))

  • 402 Accesses

Abstract

Common name in Jamaica: Cerasee

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Selected bibliography

  • Adams CD (1972) The flowering plants of Jamaica. Kingston: University of the West Indies, 848 pp.

    Google Scholar 

  • Azam M, Saerang CO, Rahayu SR, Indrawati F, Budiono I, Fibriana AI, Azinar M, Sa’dyah NAC, Cahyono EB, Lesmana R (2016) A doubled-blind, crossover-RCT in T2DM for evaluating hypoglycemic effect of P. indicus, M. charantia, P. vulgaris and A. Paniculata in Central Java. Journal of Natural Remedies 16, 108–114.

    Article  Google Scholar 

  • Baldwa VS, Bhandari C M, Pangaria A, Goyal RK (1977) Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source. Upsala Journal of Medical Sciences 82: 39-41.

    Article  CAS  Google Scholar 

  • CABI (2020) Momordica charantia (bitter gourd) [original text by Rojas-Sandoval J, Acevedo-Rodriguez P] In: Invasive Species Compendium. Wallingford, UK: CAB International. Accessed 12 January at https://www.cabi.org/isc/datasheet/34678.

    Google Scholar 

  • Cortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-Del Villar M (2018) Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus. Journal of Medicinal Food 21: 672-677.

    Article  Google Scholar 

  • Dans AM, Villarruz MV, Jimeno CA, Javelosa MA, Chua J, Bautista R, Velez GG (2007) The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. Journal of Clinical Epidemiology 60: 554-559.

    Article  Google Scholar 

  • Delgoda R, Picking D (2015) Potential drug interactions for commonly used medicinal plants & foods in Jamaica. Kingston: University of the West Indies, Natural Products Institute, 23 pp.

    Google Scholar 

  • Efird JT, Choi YM, Davies SW, Mehra S, Anderson EJ, Katunga LA (2014) Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. International Journal of Environmental Research and Public Health 11: 2328-2345.

    Article  Google Scholar 

  • Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, Ingkaninan K, Plianbangchang P, Haines ST (2011) Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. Journal of Ethnopharmacology 134: 422-428.

    Article  Google Scholar 

  • Inayat-ur-Rahman, Malik SA, Bashir M, Khan R, Iqbal M (2009) Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment. Phytomedicine 16: 401-405.

    Article  CAS  Google Scholar 

  • Izzo AA, Ernst E (2001) Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs 61: 2163-2175.

    Article  CAS  Google Scholar 

  • John AJ, Cherian R, Subhash HS, Cherian AM (2003) Evaluation of the efficacy of bitter gourd (Momordica charantia) as an oral hypoglycemic agent—a randomized controlled clinical trial. Indian Journal of Physiology and Pharmacology 47: 363-365.

    CAS  PubMed  Google Scholar 

  • Krawinkel MB, Ludwig C, Swai ME, Yang RY, Chun KP, Habicht SD (2018) Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania. Journal of Ethnopharmacology 216: 1-7.

    Article  CAS  Google Scholar 

  • Lim ST, Jimeno CA, Razon-Gonzales EB, Velasquez MEN (2010). The MOCHA DM study: The effect of Momordica charantia tablets on glucose and insulin levels during the postprandial state among patients with type 2 diabetes mellitus. Philippine Journal of Internal Medicine 48: 19–25.

    Google Scholar 

  • Natural Medicines (2015) Formerly Natural Standard and Natural Medicines Comprehensive Database. Bitter melon. Accessed 16 December 2015 at https://naturalmedicines.therapeuticresearch.com/.

  • Ooi CP, Yassin Z, Hamid TA (2012) Momordica charantia for type 2 diabetes mellitus. Cochrane Database Systematic Reviews 8: Cd007845.

    Google Scholar 

  • Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D (2019) Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. Journal of Ethnopharmacology 231:311-324.

    Article  CAS  Google Scholar 

  • Picking D, Delgoda R, Younger N, Germosen-Robineau L, Boulogne I, Mitchell S (2015) TRAMIL ethnomedicinal survey in Jamaica. Journal of Ethnopharmacology 169: 314-327.

    Article  CAS  Google Scholar 

  • Pons J, Stevenson D (1943) The effects of Momordica charantia L. (“cundeamor”) in diabetes mellitus. The Puerto Rico Journal of Public Health and Tropical Medicine 19: 196–215.

    CAS  Google Scholar 

  • Purificacion JM, Cortes-Maramba NP, Ho H (2007) Reinstating ampalaya (Momordica charantia, L.) as scientifically validated herbal medicinal plant. Departmental Circular. Office of the Secretary, Department of Health, Republic of the Philippines, issue 2007–0058.

    Google Scholar 

  • Raman A, Lau C (1996) Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine 2: 349-362.

    Article  CAS  Google Scholar 

  • Rahman IU, Khan RU, Rahman KU, Bashir M (2015) Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients. Nutrition Journal 14, 13.

    Article  Google Scholar 

  • Rosales R, Fernando R (2001) An inquiry to the hypoglycemic action of Momordica charantia among type 2 diabetes patients. Philippine Journal of Internal Medicine 39: 213–216.

    Google Scholar 

  • Shields, M (2006) The effect of Jamaican medicinal plants on the activities of cytochrome P450 enzymes. Kingston, Jamaica: University of the West Indies, MPhil Dissertation.

    Google Scholar 

  • Soo May L, Sanip Z, Ahmed Shokri A, Abdul Kadir A, Md Lazin MR (2018) The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial. Complementary Therapies in Clinical Practice 32: 181-186.

    Article  Google Scholar 

  • Suthar AC, Deshmukh A, Babu V, Mohan VS, Chavan MV Kumar D, Chauhan V, Sharma S, Sharma M (2016a) Efficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: an open label, randomized, active controlled, phase II trial. Clinical Diabetology 5: 88–94.

    Article  CAS  Google Scholar 

  • Suthar AC, Pai VG, Kadam Y, Tongaonkar A, Kale S, Deshpande AB, Kolke S, Tanna S, Deshpande SV, Chawla P, Biswas D, Sharma S (2016b) Efficacy and safety of PDM011011 capsules as compared to metformin in subjects with type-2 diabetes mellitus: An open-label, randomized, active-controlled, multicentric, phase III study. Journal of Diabetes Mellitus 6: 38–48.

    Article  CAS  Google Scholar 

  • Trakoon-osot W, Sotanaphun U, Phanachet P, Porasuphatana S, Udomsubpayakul U, Komindr S (2013) Pilot study: Hypoglycemic and antiglycation activities of bitter melon (Momordica charantia L.) in type 2 diabetic patients. Journal of Pharmacy Research 6: 859–864. https://doi.org/10.1016/j.jopr.2013.08.007.

  • TRAMIL (2016) Caribbean pharmacopeia. Momordica charantia. Accessed 27 December 2019 at http://www.tramil.net/en/plant/momordica-charantia.

  • Tsai CH, Chen EC, Tsay HS, Huang CJ (2012) Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial. Nutrition Journal 11: 4.

    Article  CAS  Google Scholar 

  • Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS (1986) Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. Journal of Ethnopharmacology 17: 277-282.

    Article  CAS  Google Scholar 

  • Zanker KS, Mang B, Wolters M, Hahn A (2012) Personalized diabetes and cancer medicine: A rationale for anti-diabetic nutrition (Bitter Melon) in a supportive setting. Current Cancer Therapies Review 8: 66–77. https://doi.org/10.2174/157339412799462521.

Download references

Author information

Authors and Affiliations

  1. Institute of Economic Botany, The New York Botanical Garden, Bronx, NY, USA

    Ina Vandebroek

  2. Natural Products Institute, The University of the West Indies, Mona, Kingston, Jamaica

    David Picking

Authors
  1. Ina Vandebroek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Picking
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vandebroek, I., Picking, D. (2020). Momordica charantia L. (Cucurbitaceae). In: Popular Medicinal Plants in Portland and Kingston, Jamaica. Advances in Economic Botany. Springer, Cham. https://doi.org/10.1007/978-3-030-48927-4_17

Download citation

Publish with us

Policies and ethics

Search

Navigation